Clinical Trials Logo

Joint Diseases clinical trials

View clinical trials related to Joint Diseases.

Filter by:

NCT ID: NCT06142669 Recruiting - Joint Diseases Clinical Trials

EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up Study Protocol

Start date: October 31, 2023
Phase:
Study type: Observational

MicroPort (MPO) is conducting this PMCF study to evaluate the safety and effectiveness of its EVOLUTION® Revision Tibial System and EVOLUTION® Revision STEMMED CS Femur with the EVOLUTION® MP CS Tibial Insert. This type of study is required by regulatory authorities for all devices that have been approved in Europe to evaluate the medium and long-term clinical evidence.

NCT ID: NCT06134310 Recruiting - Clinical trials for Temporomandibular Disorder

Efficacy of Manual Therapy Based on the Fascial Distortion Model in Individuals With Temporomandibular Disorder

Start date: November 7, 2023
Phase: N/A
Study type: Interventional

The goal of this randomized clinical trial is to investigate the efficacy of Manual Therapy Based on the Fascial Distortion Model (FDM) by comparing it with Core Stabilization Training (CST) or Control in individuals with temporomandibular disorders. The main questions it aims to answer are: - Is the efficacy of the addition of FDM-based Manual Therapy to conventional therapy different from the addition of CST or control? - Is the efficacy of the addition of CST to conventional therapy different from the addition of FDM or control? All participants in the intervention groups will be given eight-week conventional therapy (Rocabado Exercises and Patient Education) in addition to FDM-based Manual Therapy or CST. Participants in the control group will not be given any therapy during the study. Pain intensity, TMD severity, head posture, function, and disability will be assessed.

NCT ID: NCT06120023 Recruiting - Knee Arthropathy Clinical Trials

Post-Market Clinical Follow Up for Total Knee Arthroplasty System Madison

2022-07
Start date: October 17, 2023
Phase:
Study type: Observational

MADISON Total Knee Prosthesis is intended to be used for total knee arthroplasty to reduce pain and restore joint mobility of the knee. Clinical data for MADISON Total Knee Prosthesis available are not deemed sufficient to support performance and benefits claimed on the whole lifetime of the product. Thus, in order to maintain compliance with the EU regulation (2017/745) related to medical devices and following ISO 14/155:2020, SERF has set up post-market clinical follow-up study (PMCF) to confirm safety and performance of Total Knee Arthroplasty system MADISON. This study is designed to cover the expected 15-years follow-up, to retrieve data according to implant feature (Posterior Stabilized or Ultra Congruent) or fixation method and to gather data related to the revision of partial knee prosthesis. The primary objective of this study is to assess the clinical safety of MADISON total knee prostheses. The secondary objective is to evaluate the survival rates, the clinical performances and clinical benefits of MADISON total knee prosthesis.

NCT ID: NCT06096168 Recruiting - Hip Arthropathy Clinical Trials

Ambispective Study Evaluating the Clinical Results of SAGITTA EVL R Revision Stems

2022-10
Start date: April 13, 2023
Phase:
Study type: Observational

This clinical study is conducted to collect data on hip arthroplasty with the SAGITTA EVL-R revision femoral stems manufactured by SERF. In order to reflect current practice, a comprehensive and continuous series of patients will be included. This study will confirm the performance and safety of the SAGITTA EVL R revision femoral stems within the framework of MDR 2017/745 and in relation to the recommendations of the MEDDEV guide 2.7.1. Rev 4 (Clinical Evaluation Guide), which provides for a systematic procedure to monitor clinical data in order to verify the claimed performance of medical devices.

NCT ID: NCT06096155 Recruiting - Hip Arthropathy Clinical Trials

Ambispective Study to Assess the Safety and the Performance of SAGITTA EVL R Stem

2022-09
Start date: June 13, 2023
Phase:
Study type: Observational

This clinical study is conducted to collect data on hip arthroplasty with the SAGITTA EVL-R revision femoral stems manufactured by SERF. This study will confirm the performance and safety of the SAGITTA EVL R revision femoral stems within the framework of MDR 2017/745 and in relation to the recommendations of the MEDDEV guide 2.7.1. Rev 4 (Clinical Evaluation Guide), which provides for a systematic procedure to monitor clinical data in order to verify the claimed performance of medical devices. The primary objective is to evaluate the long-term survival rate (7 to 10 years post-op +/- 2 years) of SAGITTA EVL R stems. Secondary objectives are to : - study long term patient satisfaction with their hip prosthesis, - confirm the long-term safety of these implants by studying the possible complications observed, - evaluate the performance of these implants using clinical scores.

NCT ID: NCT06084403 Recruiting - Knee Osteoarthritis Clinical Trials

Ultrasound-Guided Adductor Canal Block for Total Knee Arthroplasty Surgery

Start date: December 20, 2023
Phase: N/A
Study type: Interventional

The ultrasound-guided selective blockade of the saphenous nerve in the adductor canal provides effective analgesia and reduces postoperative pain in patients undergoing arthroscopic medial meniscectomy. Selective blockade of the saphenous nerve in the adductor canal provides effective analgesia without quadriceps muscle weakness. It has been shown that the adductor canal block (ACB) block increases the spread of local anesthetics in a distal and proximal way. Therefore, the proximal spread of local anesthetics may cause possible quadriceps weakness. The distal spread of local anesthetics may increase analgesic effect via sciatic nerve. The different volumes for ACB is a topic of discussion. The aim of this study is to compare the different volumes of US-guided ACB performing for postoperative analgesia management after total knee arthroplasty surgery.

NCT ID: NCT06074744 Recruiting - Joint Diseases Clinical Trials

Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty

Start date: November 30, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare two different types of nerve blocks in patients undergoing surgery for primary Total Knee Arthroplasty. The main question aim to answer is: - is there a benefit in functional muscle power output of the leg? Participants will be randomized into either the intervention group or the control group and: - receive Subsartorial Saphenous Nerve Block (SSNB) + IPACK in intervention group (group 1) - receive Femoral Nerve Block (FNB) + IPACK in control group (group 2) Researchers will compare the 2 groups to see if there are differences in : - functional muscle power output of the leg? - muscle function, mobility, clinical and radiological results, ROM, pain control (NRS), opioid consumption, length of hospital stay, patient satisfaction, mobility, reduction of costs?

NCT ID: NCT06053008 Recruiting - Pain Clinical Trials

The Relationship Between Pain Perception, Severity of Temporomandibular Joint Dysfunction, and Spinal Health in Geriatric Individuals

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

It is aimed to examine the relationship between pain perception, temporomandibular joint disorder severity and spine health in elderly individuals.

NCT ID: NCT06052735 Recruiting - Pain Clinical Trials

Association Among Pain Perception, Severity of Temporomandibular Joint Dysfunction, and Spinal Health in Caregivers of Stroke Individuals

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

This study aims to examine pain perception, temporomandibular disorder severity and spine health in caregivers of stroke patients.

NCT ID: NCT06046521 Recruiting - Clinical trials for Temporomandibular Joint Disorders

Impact of Temporomandibular Joint Dysfunction on Objective and Subjective Vocal Measures

Start date: September 20, 2023
Phase:
Study type: Observational

The present study aims to investigate the impact of temporomandibular joint dysfunction (TMD) on objective and subjective vocal parameters and the quality of life in affected patients. TMD is a pervasive public health issue that impacts approximately 25% of the general population and is notably more prevalent among women. The etiology of TMD is multi-factorial, with known risk factors such as parafunctional habits, emotional stress, occlusion issues, and orthodontic treatments. Internal derangements of the temporomandibular joint are the most common subtype of TMD, characterized by symptoms such as pain, joint noises, restricted mouth opening, and masticatory dysfunction. This study particularly focuses on the limitations in mouth opening due to TMD and its effects on vocal characteristics and quality of life. Conservative treatment methods, such as non-steroidal anti-inflammatory drugs (NSAIDs) and occlusal splints, have been effective in symptom management unless there is clear evidence of joint collapse or ankylosis. The null hypothesis (H0) posits that the restriction in mouth opening has no impact on vocal parameters or quality of life.